Total Payments
$1.0M
2024 Payments
$122,284
Companies
37
Transactions
1,644
Medicare Patients
2,611
Medicare Billing
$389,336
Payment Breakdown by Category
Other$564,285 (56.4%)
Consulting$313,159 (31.3%)
Travel$91,584 (9.1%)
Food & Beverage$31,748 (3.2%)
Gifts$373.28 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $366,897 | 119 | 36.6% |
| Consulting Fee | $313,159 | 156 | 31.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $113,863 | 35 | 11.4% |
| Travel and Lodging | $91,584 | 523 | 9.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $53,450 | 22 | 5.3% |
| Food and Beverage | $31,748 | 769 | 3.2% |
| Honoraria | $30,076 | 19 | 3.0% |
| Gift | $373.28 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $252,748 | 553 | $0 (2019) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $176,107 | 244 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $149,016 | 214 | $0 (2024) |
| Sight Sciences, Inc. | $144,383 | 126 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $60,694 | 107 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $55,730 | 76 | $0 (2023) |
| Kala Pharmaceuticals, Inc. | $42,994 | 67 | $0 (2021) |
| EYEVANCE PHARMACEUTICALS LLC | $27,847 | 50 | $0 (2022) |
| Valeant Pharmaceuticals North America LLC | $22,616 | 40 | $0 (2017) |
| Johnson & Johnson Vision Care, Inc. | $15,409 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $122,284 | 241 | Bausch & Lomb Americas Inc. ($79,869) |
| 2023 | $135,317 | 178 | Bausch & Lomb Americas Inc. ($57,792) |
| 2022 | $140,362 | 166 | Sun Pharmaceutical Industries Inc. ($76,051) |
| 2021 | $124,584 | 146 | Kala Pharmaceuticals, Inc. ($41,089) |
| 2020 | $69,494 | 92 | Sight Sciences, Inc. ($29,109) |
| 2019 | $140,116 | 217 | Shire North American Group Inc ($56,230) |
| 2018 | $133,659 | 273 | Shire North American Group Inc ($103,063) |
| 2017 | $135,333 | 331 | Shire North American Group Inc ($93,456) |
All Payment Transactions
1,644 individual payment records from CMS Open Payments — Page 66 of 66
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/12/2017 | Shire North American Group Inc | XIIDRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: OPTHALMICS | ||||||
| 01/12/2017 | Shire North American Group Inc | XIIDRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: OPTHALMICS | ||||||
| 01/12/2017 | Shire North American Group Inc | — | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| 01/12/2017 | Shire North American Group Inc | — | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| 01/12/2017 | Shire North American Group Inc | — | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| 01/12/2017 | Shire North American Group Inc | XIIDRA (Drug) | Travel and Lodging | In-kind items and services | $110.16 | General |
| Category: OPTHALMICS | ||||||
| 01/12/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $103.38 | General |
| Category: OPTHALMICS | ||||||
| 01/12/2017 | Shire North American Group Inc | XIIDRA (Drug) | Travel and Lodging | In-kind items and services | $27.00 | General |
| Category: OPTHALMICS | ||||||
| 01/12/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: OPTHALMICS | ||||||
| 01/12/2017 | Shire North American Group Inc | XIIDRA (Drug) | Travel and Lodging | In-kind items and services | $23.00 | General |
| Category: OPTHALMICS | ||||||
| 01/12/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: OPTHALMICS | ||||||
| 01/12/2017 | Shire North American Group Inc | XIIDRA (Drug) | Travel and Lodging | In-kind items and services | $13.98 | General |
| Category: OPTHALMICS | ||||||
| 01/12/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: OPTHALMICS | ||||||
| 01/12/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: OPTHALMICS | ||||||
| 01/09/2017 | Beaver-Visitec International, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 01/05/2017 | Shire North American Group Inc | XIIDRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: OPTHALMICS | ||||||
| 01/05/2017 | Alcon Laboratories Inc | Pazeo (Drug) | Travel and Lodging | Cash or cash equivalent | $98.28 | General |
| Category: Ophthalmology | ||||||
| 01/04/2017 | Valeant Pharmaceuticals North America LLC | BESIVANCE (Drug), ZYLET | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/03/2017 | Alcon Laboratories Inc | Pazeo (Drug) | Travel and Lodging | Cash or cash equivalent | $27.00 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 712 | 900 | $223,975 | $109,662 |
| 2022 | 8 | 644 | 831 | $238,825 | $103,392 |
| 2021 | 8 | 644 | 817 | $239,300 | $96,497 |
| 2020 | 11 | 611 | 816 | $193,545 | $79,785 |
Total Patients
2,611
Total Services
3,364
Medicare Billing
$389,336
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 65778 | Placement of amniotic membrane on eye surface for wound healing | Office | 2023 | 27 | 41 | $69,700 | $44,735 | 64.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 229 | 375 | $46,875 | $24,220 | 51.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 178 | 184 | $27,600 | $16,503 | 59.8% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 84 | 96 | $57,000 | $15,548 | 27.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 48 | 56 | $5,600 | $2,702 | 48.2% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 24 | 24 | $4,800 | $2,351 | 49.0% |
| 92134 | Imaging of retina | Office | 2023 | 60 | 60 | $6,000 | $1,801 | 30.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 32 | 33 | $3,300 | $952.32 | 28.9% |
| 92250 | Photography of the retina | Office | 2023 | 30 | 31 | $3,100 | $849.76 | 27.4% |
| 65778 | Placement of amniotic membrane on eye surface for wound healing | Office | 2022 | 21 | 35 | $59,500 | $41,123 | 69.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 233 | 367 | $45,875 | $22,475 | 49.0% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 110 | 127 | $92,400 | $20,439 | 22.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 136 | 151 | $22,650 | $12,036 | 53.1% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 33 | 33 | $6,600 | $3,152 | 47.8% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 48 | 54 | $5,400 | $2,491 | 46.1% |
| 92134 | Imaging of retina | Office | 2022 | 39 | 39 | $3,900 | $1,097 | 28.1% |
| 92133 | Imaging of optic nerve | Office | 2022 | 24 | 25 | $2,500 | $578.16 | 23.1% |
| 68761 | Closure of tear duct opening using plug | Office | 2021 | 136 | 153 | $116,800 | $27,241 | 23.3% |
| 65778 | Insertion of amniotic membrane to eye surface | Office | 2021 | 16 | 20 | $34,000 | $24,907 | 73.3% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 186 | 320 | $40,000 | $21,751 | 54.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 166 | 173 | $25,950 | $15,069 | 58.1% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 64 | 74 | $12,850 | $3,564 | 27.7% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 20 | 20 | $4,000 | $2,182 | 54.5% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 32 | 33 | $3,300 | $1,079 | 32.7% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 24 | 24 | $2,400 | $704.62 | 29.4% |
About Dr. Derek Cunningham, O.D
Dr. Derek Cunningham, O.D is a Optometrist healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265407084.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Derek Cunningham, O.D has received a total of $1.0M in payments from pharmaceutical and medical device companies, with $122,284 received in 2024. These payments were reported across 1,644 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($366,897).
As a Medicare-enrolled provider, Cunningham has provided services to 2,611 Medicare beneficiaries, totaling 3,364 services with total Medicare billing of $389,336. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Other Specialties Optometrist
- Location Austin, TX
- Active Since 02/23/2006
- Last Updated 10/21/2014
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1265407084
Products in Payments
- XIIDRA (Drug) $313,547
- Cequa (Drug) $170,782
- MIEBO (Drug) $97,425
- TearCare SmartLid (Device) $71,973
- EYSUVIS (Drug) $42,909
- TearCare (Device) $39,549
- TEARCARE SYSTEM (Device) $32,861
- VYZULTA (Drug) $31,467
- LOTEMAX SM (Drug) $22,073
- ZYLET (Drug) $20,463
- Acuvue (Device) $15,409
- Flarex (Drug) $13,029
- Tecnis 1-piece IOL (Device) $11,329
- BESIVANCE (Drug) $11,004
- TYRVAYA (Drug) $9,589
- Tobradex ST (Drug) $8,007
- VEVYE (Drug) $6,842
- Zerviate (Drug) $6,788
- LOTEMAX GEL (Drug) $5,994
- CEQUA (Drug) $4,392
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Austin
Emil Fadel, O.d, O.D
Optometrist — Payments: $309,786
Optometrist $309,786
Drew Provost, O.d, O.D
Optometrist — Payments: $36,981
Optometrist $36,981
Shannon Wong, Md, MD
Optometrist — Payments: $19,709
Optometrist $19,709
Dr. Robert Soltys, O.d, O.D
Optometrist — Payments: $14,188
Optometrist $14,188
Dr. Marisol Gomez, O.d, O.D
Optometrist — Payments: $12,613
Optometrist $12,613
Danny Bristol, Od, OD
Optometrist — Payments: $11,476
Optometrist $11,476